Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083203
Filing Date
2025-06-06
Accepted
2025-06-06 16:48:36
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5454
  Complete submission text file 0000950170-25-083203.txt   6927
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 WEST 11TH STREET KANSAS CITY MO 64105
Business Address
Bleil Lynn Dorsey (Reporting) CIK: 0001607309 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33497 | Film No.: 251031422